{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:09:04Z","timestamp":1786997344244,"version":"build-2736575974"},"reference-count":111,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.tcm.2022.04.007","type":"journal-article","created":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T11:24:09Z","timestamp":1651317849000},"page":"442-455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Update on cardiac sarcoidosis"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1083-8259","authenticated-orcid":false,"given":"Jian Liang","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan E-Xin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim W","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Ortman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin Z.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5649","key":"10.1016\/j.tcm.2022.04.007_bib0001","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/bmj.2.5649.109","article-title":"Centenary commemoration of sarcoidosis and of Jonathan Hutchinson","volume":"2","author":"James","year":"1969","journal-title":"Br Med J"},{"issue":"21","key":"10.1016\/j.tcm.2022.04.007_bib0002","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.tcm.2022.04.007_bib0003","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.jacc.2020.08.042","article-title":"Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review","volume":"76","author":"Trivieri","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2022.04.007_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8480-0","article-title":"Sarcoidosis: a Critical Review of History and Milestones","volume":"49","author":"Spagnolo","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac Sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.tcm.2022.04.007_bib0006","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.amjcard.2018.10.021","article-title":"Cardiac Sarcoidosis","volume":"123","author":"Tan","year":"2019","journal-title":"Am J Cardiol"},{"issue":"7-8","key":"10.1016\/j.tcm.2022.04.007_bib0007","first-page":"372","article-title":"Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan","volume":"43","author":"Iwai","year":"1993","journal-title":"Acta Pathol Jpn"},{"issue":"6","key":"10.1016\/j.tcm.2022.04.007_bib0008","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0009","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s12350-016-0658-1","article-title":"Isolated cardiac sarcoidosis: A focused review of an under-recognized entity","volume":"25","author":"Okada","year":"2018","journal-title":"J Nucl Cardiol"},{"issue":"20","key":"10.1016\/j.tcm.2022.04.007_bib0010","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0011","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10554-020-02090-2","article-title":"Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study","volume":"37","author":"Kebed","year":"2021","journal-title":"Int J Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.tcm.2022.04.007_bib0012","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.tcm.2022.04.007_bib0013","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis- Digest Version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"issue":"9","key":"10.1016\/j.tcm.2022.04.007_bib0014","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2022.04.007_bib0015","first-page":"26","article-title":"Racial difference in cardiac sarcoidosis incidence observed at autopsy","volume":"11","author":"Iwai","year":"1994","journal-title":"Sarcoidosis"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0016","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"Tavora","year":"2009","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.tcm.2022.04.007_bib0017","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1002\/ehf2.12853","article-title":"Diagnosis of isolated cardiac sarcoidosis based on new guidelines","volume":"7","author":"Kawai","year":"2020","journal-title":"ESC Heart Fail"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0018","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cardfail.2014.12.004","article-title":"Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography\/computerized tomography","volume":"21","author":"Tezuka","year":"2015","journal-title":"J Card Fail"},{"issue":"7","key":"10.1016\/j.tcm.2022.04.007_bib0019","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jacc.2020.06.038","article-title":"Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis","volume":"76","author":"Yafasova","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.tcm.2022.04.007_bib0020","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of Sarcoidosis and Its Management","volume":"385","author":"Drent","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.tcm.2022.04.007_bib0021","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/jmedgenet-2013-101532","article-title":"Recent advances in the genetics of sarcoidosis","volume":"50","author":"Spagnolo","year":"2013","journal-title":"J Med Genet"},{"issue":"9","key":"10.1016\/j.tcm.2022.04.007_bib0022","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ng.198","article-title":"Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis","volume":"40","author":"Hofmann","year":"2008","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.tcm.2022.04.007_bib0023","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1165\/ajrcmb.25.3.4261","article-title":"Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis","volume":"25","author":"Foley","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0024","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1399-0039.1994.tb02331.x","article-title":"Molecular genetic studies of HLA class II alleles in sarcoidosis","volume":"43","author":"Ishihara","year":"1994","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1519","article-title":"Sarcoidosis is associated with a truncating splice site mutation in BTNL2","volume":"37","author":"Valentonyte","year":"2005","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0026","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1183\/09031936.00033812","article-title":"Genome-wide association analysis reveals 12q13.3-q14.1 as new risk locus for sarcoidosis","volume":"41","author":"Hofmann","year":"2013","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.tcm.2022.04.007_bib0027","doi-asserted-by":"crossref","first-page":"e92646","DOI":"10.1371\/journal.pone.0092646","article-title":"Admixture fine-mapping in African Americans implicates XAF1 as a possible sarcoidosis risk gene","volume":"9","author":"Levin","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.tcm.2022.04.007_bib0028","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/JCM.40.1.198-204.2002","article-title":"Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis","volume":"40","author":"Eishi","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0029","first-page":"262","article-title":"Role of Propionibacterium Acnes in Sarcoidosis: A Meta-analysis","volume":"30","author":"Zhou","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"10.1016\/j.tcm.2022.04.007_bib0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/ACI.0b013e3283515173","article-title":"Occupational causes of sarcoidosis","volume":"12","author":"Newman","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.tcm.2022.04.007_bib0031","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-2007-970332","article-title":"Pathology of sarcoidosis","volume":"28","author":"Rosen","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.tcm.2022.04.007_bib0032","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.semdp.2007.06.002","article-title":"The pathology of pulmonary sarcoidosis: update","volume":"24","author":"Ma","year":"2007","journal-title":"Semin Diagn Pathol"},{"issue":"10","key":"10.1016\/j.tcm.2022.04.007_bib0033","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011253","article-title":"Myocardial Involvement in Patients With Histologically Diagnosed Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis of Gross Pathological Images From Autopsy or Cardiac Transplantation Cases","volume":"8","author":"Okasha","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"37","key":"10.1016\/j.tcm.2022.04.007_bib0034","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/eurheartj\/ehz428","article-title":"Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries","volume":"40","author":"Ekstrom","year":"2019","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0035","article-title":"Cardiac sarcoidosis presenting with syncope and rapidly progressive atrioventricular block: a case report","volume":"2","author":"Tan","year":"2018","journal-title":"Eur Heart J Case Rep"},{"issue":"12","key":"10.1016\/j.tcm.2022.04.007_bib0036","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/CIRCULATIONAHA.118.034687","article-title":"Ventricular Arrhythmias in Cardiac Sarcoidosis","volume":"138","author":"Okada","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.tcm.2022.04.007_bib0037","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta","year":"2008","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.tcm.2022.04.007_bib0038","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.006145","article-title":"Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block","volume":"11","author":"Nordenswan","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0039","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.amjcard.2014.11.028","article-title":"Outcomes in patients with high-degree atrioventricular block as the initial manifestation of cardiac sarcoidosis","volume":"115","author":"Takaya","year":"2015","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.tcm.2022.04.007_bib0040","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jacep.2021.01.022","article-title":"Incidence and Predictors of Sudden Cardiac Arrest in Sarcoidosis: A Nationwide Analysis","volume":"7","author":"Narasimhan","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"issue":"5","key":"10.1016\/j.tcm.2022.04.007_bib0041","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017692","article-title":"Heart Failure, Atrioventricular Block, and Ventricular Tachycardia in Sarcoidosis","volume":"10","author":"Rosenthal","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.tcm.2022.04.007_bib0042","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003738","article-title":"Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance","volume":"9","author":"Murtagh","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.tcm.2022.04.007_bib0043","first-page":"208","article-title":"Heart transplantation for advanced heart failure due to cardiac sarcoidosis","volume":"32","author":"Theofilogiannakos","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0044","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ehf2.12166","article-title":"Right ventricular involvement in cardiac sarcoidosis demonstrated with cardiac magnetic resonance","volume":"4","author":"Smedema","year":"2017","journal-title":"ESC Heart Fail"},{"issue":"3","key":"10.1016\/j.tcm.2022.04.007_bib0045","first-page":"443","article-title":"Group 5 Pulmonary Hypertension: The Orphan's Orphan Disease","volume":"34","author":"Kalantari","year":"2016","journal-title":"Cardiol Clin"},{"issue":"6","key":"10.1016\/j.tcm.2022.04.007_bib0046","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCEP.113.000156","article-title":"Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias","volume":"7","author":"Crawford","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0047","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/clc.4960270409","article-title":"Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome","volume":"27","author":"Furushima","year":"2004","journal-title":"Clin Cardiol"},{"issue":"8","key":"10.1016\/j.tcm.2022.04.007_bib0048","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.hrthm.2006.03.031","article-title":"Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation","volume":"3","author":"Koplan","year":"2006","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.tcm.2022.04.007_bib0049","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/CIRCEP.113.000734","article-title":"Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis","volume":"7","author":"Naruse","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"10.1016\/j.tcm.2022.04.007_bib0050","first-page":"210","article-title":"Ventricular tachycardia storm successfully treated with immunosuppression and catheter ablation in a patient with cardiac sarcoidosis","volume":"22","author":"Stees","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"10.1016\/j.tcm.2022.04.007_bib0051","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1542-474X.2011.00418.x","article-title":"Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"16","author":"Yodogawa","year":"2011","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"3","key":"10.1016\/j.tcm.2022.04.007_bib0052","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacep.2017.09.175","article-title":"Characterization of the Electroanatomic Substrate in Cardiac Sarcoidosis: Correlation With Imaging Findings of Scar and Inflammation","volume":"4","author":"Muser","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"8","key":"10.1016\/j.tcm.2022.04.007_bib0053","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/jce.13228","article-title":"Tailored approach for management of ventricular tachycardia in cardiac sarcoidosis","volume":"28","author":"Yalagudri","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0054","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.tcm.2022.04.007_bib0055","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.hrthm.2007.06.006","article-title":"Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis","volume":"4","author":"Banba","year":"2007","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1016\/j.tcm.2022.04.007_bib0056","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"issue":"12","key":"10.1016\/j.tcm.2022.04.007_bib0057","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","article-title":"Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis","volume":"10","author":"Kouranos","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"32","key":"10.1016\/j.tcm.2022.04.007_bib0058","doi-asserted-by":"crossref","first-page":"e4518","DOI":"10.1097\/MD.0000000000004518","article-title":"Prevalence of cardiac sarcoidosis in white population: a case-control study: Proposal for a novel risk index based on commonly available tests","volume":"95","author":"Martusewicz-Boros","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.tcm.2022.04.007_bib0059","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1536\/ihj.17-695","article-title":"A Multiple Biomarker Approach in Patients with Cardiac Sarcoidosis","volume":"59","author":"Kiko","year":"2018","journal-title":"Int Heart J"},{"issue":"6","key":"10.1016\/j.tcm.2022.04.007_bib0060","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.amjcard.2015.06.021","article-title":"Usefulness of Cardiac Troponins as Markers of Early Treatment Response in Cardiac Sarcoidosis","volume":"116","author":"Kandolin","year":"2015","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.tcm.2022.04.007_bib0061","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1253\/circj.CJ-14-1217","article-title":"Association Between Basal Thinning of Interventricular Septum and Adverse Long-Term Clinical Outcomes in Patients With Cardiac Sarcoidosis","volume":"79","author":"Nagano","year":"2015","journal-title":"Circ J"},{"issue":"1","key":"10.1016\/j.tcm.2022.04.007_bib0062","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ejhf.205","article-title":"Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis","volume":"17","author":"Joyce","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0063","article-title":"Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study","volume":"38","author":"Huitema","year":"2022","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"19","key":"10.1016\/j.tcm.2022.04.007_bib0064","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1161\/CIRCULATIONAHA.107.186093","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology","volume":"116","author":"Cooper","year":"2007","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.tcm.2022.04.007_bib0065","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.120.046900","article-title":"Diagnostic Yield of Electroanatomic Voltage Mapping in Guiding Endomyocardial Biopsies","volume":"142","author":"Casella","year":"2020","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.tcm.2022.04.007_bib0066","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1001\/jama.2013.5823","article-title":"Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial","volume":"309","author":"von Bartheld","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.tcm.2022.04.007_bib0067","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/MCP.0b013e32832ea4c7","article-title":"Cardiac imaging in myocardial sarcoidosis and other cardiomyopathies","volume":"15","author":"Sharma","year":"2009","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0068","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2022.04.007_bib0069","article-title":"Cardiac Magnetic Resonance Imaging for Diagnosis of Cardiac Sarcoidosis: A Meta-Analysis","volume":"2018","author":"Zhang","year":"2018","journal-title":"Can Respir J"},{"issue":"11","key":"10.1016\/j.tcm.2022.04.007_bib0070","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005022","article-title":"Comprehensive Cardiovascular Magnetic Resonance Assessment in Patients With Sarcoidosis and Preserved Left Ventricular Ejection Fraction","volume":"9","author":"Greulich","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.tcm.2022.04.007_bib0071","first-page":"1989","article-title":"Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis","volume":"45","author":"Okumura","year":"2004","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.tcm.2022.04.007_bib0072","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s12350-009-9110-0","article-title":"Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis","volume":"16","author":"Langah","year":"2009","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"10.1016\/j.tcm.2022.04.007_bib0073","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.tcm.2022.04.007_bib0074","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.jcmg.2020.11.016","article-title":"Pre-Treatment Myocardial (18)FDG Uptake Predicts Response to Immunosuppression in Patients With Cardiac Sarcoidosis","volume":"14","author":"Subramanian","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.tcm.2022.04.007_bib0075","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.hrthm.2015.06.032","article-title":"Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block","volume":"12","author":"Orii","year":"2015","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.tcm.2022.04.007_bib0076","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jcmg.2021.05.023","article-title":"Pulmonary Artery (18)F-Fluorodeoxyglucose Uptake by PET\/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis","volume":"15","author":"Maier","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2022.04.007_bib0077","article-title":"Sarcoidosis: Pitfalls and Challenging Mimickers","volume":"7","author":"Narula","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.tcm.2022.04.007_bib0078","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCEP.113.000932","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear","volume":"7","author":"Philips","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"10.1016\/j.tcm.2022.04.007_bib0079","first-page":"50","article-title":"Cardiac sarcoidosis-state of the art review","volume":"6","author":"Hulten","year":"2016","journal-title":"Cardiovasc Diagn Ther"},{"issue":"3","key":"10.1016\/j.tcm.2022.04.007_bib0080","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17996\/anc.17-00042","article-title":"New guidelines for diagnosis of cardiac sarcoidosis in Japan","author":"Terasaki","year":"2017","journal-title":"Ann Nucl Cardiol"},{"key":"10.1016\/j.tcm.2022.04.007_bib0081","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ahj.2020.02.008","article-title":"Performance of diagnostic criteria in patients clinically judged to have cardiac sarcoidosis: Is it time to regroup?","volume":"223","author":"Ribeiro Neto","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2022.04.007_bib0082","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021183","article-title":"Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review","author":"Fazelpour","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0083","doi-asserted-by":"crossref","DOI":"10.1148\/ryct.2020190140","article-title":"Utility of FDG PET and Cardiac MRI in Diagnosis and Monitoring of Immunosuppressive Treatment in Cardiac Sarcoidosis","volume":"2","author":"Coulden","year":"2020","journal-title":"Radiol Cardiothorac Imaging"},{"issue":"1","key":"10.1016\/j.tcm.2022.04.007_bib0084","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in (1)(8)F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol"},{"issue":"18","key":"10.1016\/j.tcm.2022.04.007_bib0085","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010952","article-title":"Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis","volume":"8","author":"Rosenthal","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2022.04.007_bib0086","doi-asserted-by":"crossref","DOI":"10.1016\/j.cardfail.2021.06.010","article-title":"Management of Cardiac Sarcoidosis Using Mycophenolate Mofetil as a Steroid-Sparing Agent","author":"Griffin","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.tcm.2022.04.007_bib0087","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijcard.2021.02.022","article-title":"Effectiveness and safety of infliximab in cardiac Sarcoidosis","volume":"330","author":"Bakker","year":"2021","journal-title":"Int J Cardiol"},{"issue":"10","key":"10.1016\/j.tcm.2022.04.007_bib0088","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.amjcard.2019.07.067","article-title":"Infliximab for Refractory Cardiac Sarcoidosis","volume":"124","author":"Harper","year":"2019","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.tcm.2022.04.007_bib0089","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.healun.2020.08.001","article-title":"Tumor necrosis factor-alpha inhibitor use for treatment of refractory cardiac sarcoidosis in a patient with left ventricular assist device: Adalimumab use in refractory sarcoidosis in a patient with left ventricular assist device","volume":"39","author":"Krishnan","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.tcm.2022.04.007_bib0090","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ahj.2019.10.003","article-title":"Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT)","volume":"220","author":"Birnie","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2022.04.007_bib0091","unstructured":"Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis. https:\/\/ClinicalTrialsgov\/show\/NCT04017936."},{"issue":"1","key":"10.1016\/j.tcm.2022.04.007_bib0092","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCEP.114.002145","article-title":"Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation","volume":"8","author":"Kumar","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0093","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.hroo.2021.07.005","article-title":"Management of ventricular tachycardia in patients with cardiac sarcoidosis","volume":"2","author":"Viwe","year":"2021","journal-title":"Heart Rhythm O2"},{"issue":"9","key":"10.1016\/j.tcm.2022.04.007_bib0094","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1540-8167.2012.02350.x","article-title":"Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis","volume":"23","author":"Schuller","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"10","key":"10.1016\/j.tcm.2022.04.007_bib0095","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.hrcr.2020.06.028","article-title":"High-dose intravenous glucocorticoids are effective in the acute management of ventricular arrhythmias in cardiac sarcoidosis: A case series","volume":"6","author":"Slivnick","year":"2020","journal-title":"HeartRhythm Case Rep"},{"issue":"2","key":"10.1016\/j.tcm.2022.04.007_bib0096","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jamacardio.2021.4738","article-title":"Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis","volume":"7","author":"Siontis","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.tcm.2022.04.007_bib0097","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006685","article-title":"Which Patients With Cardiac Sarcoidosis Should Receive Implantable Cardioverter-Defibrillators: Some Answers but Many Questions Remain","volume":"11","author":"Birnie","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"10.1016\/j.tcm.2022.04.007_bib0098","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.jacc.2012.11.007","volume":"61","author":"Epstein","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.tcm.2022.04.007_bib0099","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/jce.12302","article-title":"Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator","volume":"25","author":"Mohsen","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"10.1016\/j.tcm.2022.04.007_bib0100","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.hrthm.2012.02.010","article-title":"Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators","volume":"9","author":"Betensky","year":"2012","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.tcm.2022.04.007_bib0101","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/eus316","article-title":"Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"15","author":"Kron","year":"2013","journal-title":"Europace"},{"issue":"14","key":"10.1016\/j.tcm.2022.04.007_bib0102","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.tcm.2022.04.007_bib0103","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0104","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.tcm.2022.04.007_bib0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCEP.110.958322","article-title":"Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation","volume":"4","author":"Mehta","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"10","key":"10.1016\/j.tcm.2022.04.007_bib0106","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1111\/jce.14058","article-title":"Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic function","volume":"30","author":"Zipse","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"7","key":"10.1016\/j.tcm.2022.04.007_bib0107","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jacc.2018.10.043","volume":"74","author":"Kusumoto","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.tcm.2022.04.007_bib0108","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.amjcard.2018.09.044","article-title":"Effect of Cardiac Resynchronization Therapy on Left Ventricular Remodeling in Patients With Cardiac Sarcoidosis","volume":"123","author":"Patel","year":"2019","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0109","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00465-2017","article-title":"Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension","volume":"50","author":"Boucly","year":"2017","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.tcm.2022.04.007_bib0110","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1378\/chest.13-1766","article-title":"Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial","volume":"145","author":"Baughman","year":"2014","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.tcm.2022.04.007_bib0111","first-page":"184","article-title":"Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertension","volume":"37","author":"Abston","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173822000664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173822000664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T05:03:01Z","timestamp":1760936581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173822000664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":111,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1050173822000664"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2022.04.007","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on cardiac sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2022.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}